Free Trial
NYSE:SYK

Stryker Q3 2025 Earnings Report

Stryker logo
$370.59 +4.19 (+1.14%)
Closing price 10/3/2025 03:59 PM Eastern
Extended Trading
$369.14 -1.44 (-0.39%)
As of 10/3/2025 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stryker EPS Results

Actual EPS
N/A
Consensus EPS
$3.14
Beat/Miss
N/A
One Year Ago EPS
N/A

Stryker Revenue Results

Actual Revenue
N/A
Expected Revenue
$6.04 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Stryker Announcement Details

Quarter
Q3 2025
Time
After Market Closes
Conference Call Date
Thursday, October 30, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Stryker Earnings Headlines

Brokerages Set Stryker Corporation (NYSE:SYK) PT at $430.33
Lost Decade warning – do this now
With the Magnificent 7 trading at bubble-like valuations, another “Lost Decade” could be looming — but Porter Stansberry says a handful of obscure “America’s Lost Stocks” have quietly delivered 1,100%–2,900% gains and may be the safest path forward now.tc pixel
Stryker (NYSE:SYK) Cut to "Hold" at Wall Street Zen
See More Stryker Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Stryker? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Stryker and other key companies, straight to your email.

About Stryker

Stryker (NYSE:SYK) is a leading global medical technology company specializing in innovative healthcare solutions. The company develops, manufactures and sells a diverse range of products and services in three primary segments: Orthopedics, MedSurg and Neurotechnology & Spine. Its Orthopedics division offers joint replacement implants, trauma products and reconstructive solutions, while its MedSurg segment provides surgical equipment, endoscopic and communications systems, patient handling and emergency medical equipment. The Neurotechnology & Spine group focuses on devices for the management of neurological and spinal disorders, including implants for spinal fusion, aneurysm treatment and brainshunt procedures.

Founded in 1941 by Dr. Homer Stryker in Kalamazoo, Michigan, the company grew from a small medical device shop into a Fortune 500 enterprise. Throughout its history, Stryker has expanded its product portfolio and geographic footprint through internal research and strategic acquisitions. Key acquisitions have included companies specializing in robotic surgery, wound care and advanced imaging, which have enhanced Stryker’s ability to offer end-to-end surgical solutions and minimally invasive treatment options.

Today, Stryker operates in more than 100 countries with manufacturing facilities, research and development centers and sales offices across North America, Europe, Asia Pacific, Latin America and the Middle East. The company invests heavily in R&D to advance technologies such as surgical robotics, digital operating room integration and personalized orthopedics. Its global supply chain and localized customer support help ensure timely product delivery and training for healthcare professionals.

Under the leadership of President and Chief Executive Officer Kevin A. Lobo, who has guided the company since 2012, Stryker emphasizes a culture of integrity, innovation and customer focus. The executive team maintains a commitment to quality, compliance and continuous improvement, while fostering collaboration with clinicians, researchers and industry partners to address evolving patient needs and drive long-term growth.

View Stryker Profile

More Earnings Resources from MarketBeat